Vaccine-preventable infections (VPIs) continue to contribute significantly to morbidity and
mortality in solid organ transplant (SOT) recipients. 1 As transplant recipients are at an …

Introduction: In solid organ transplant (SOT) recipients, influenza is associated with
significant morbidity, including high hospital admission and mortality rates. Influenza may …

Transplant recipients were excluded from the initial clinical trials determining safety and
efficacy of the landmark COVID-19 vaccines. Further, there is increasing evidence that …

Background We assessed cell-mediated immune (CMI) responses of influenza vaccination
in patients with cancer receiving immune checkpoint inhibitors (ICIs), which remain elusive …

Background High-dose (HD) influenza vaccine offers improved protection from influenza
virus infection among older adults compared with standard-dose (SD) vaccine. Here, we …

Little is known about cell-mediated immune responses to natural influenza infection in solid
organ transplant (SOT) patients. The aim of our study was to evaluate the CD4+ and CD8+ …

Lung transplant patients are at increased risk of infection due to immunosuppression.
Vaccination is a key source of protection; however, after transplant, patients tend to have …

Background The use of vaccination to prevent infection has a long history, starting in the
1700s with Jenner. New innovations have led to improvements in the safety and efficacy of …

Abstract Purpose of Review To review the recent literature surrounding immune responses
to influenza vaccination in solid organ transplant (SOT) recipients, in addition to reviewing …

Introduction In solid organ transplant (SOT) recipients, viral infections are associated with
direct morbidity and mortality and may influence long-term allograft outcomes. Prevention of …